Harvest Group Wealth Management, LLC Uni Qure N.V. Transaction History

Harvest Group Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$29.24 - $42.03 $19,503 - $28,034	-667 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$45.06 - $67.74 $7,660 - $11,515	170 Added 34.21%	667 $30,000
Q2 2019 Jul 31, 2019	BUY	$52.76 - $82.19 $3,060 - $4,767	58 Added 13.21%	497 $38,000
Q1 2019 May 06, 2019	BUY	$27.39 - $68.41 $12,024 - $30,031	439 New	439 $26,000

171

42.5M

2.61M

582K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $690M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.